BioCentury
ARTICLE | Clinical News

FDA approves adjuvanted seasonal flu vaccine

November 26, 2015 12:04 AM UTC

FDA granted accelerated approval to Fluad, an MF59-adjuvanted influenza vaccine from Novartis AG (NYSE:NVS; SIX:NOVN), to prevent seasonal influenza in people aged 65 and older. The vaccine is the fir...